New targeted treatment for ovarian cancer using radiopharmaceuticals
A novel platform for targeted radiopharmaceuticals for imaging and therapy of ovarian cancer
This study is testing a new treatment for ovarian cancer that aims to help doctors see the cancer better and treat it more effectively by using a special compound that targets a specific part of the cancer cells.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oncurie INC. NIH-funded |
| Lab location | 1 site (Raleigh, United States) |
| Project ID | NIH-10918937 on NIH RePORTER |
What this research studies
This research focuses on developing a novel compound that targets ovarian cancer by binding to the folate receptor, which is often overexpressed in ovarian cancer cells. The compound is designed to deliver radionuclides for both imaging and therapy, aiming to improve early detection and treatment outcomes. By utilizing a proprietary moiety, the research seeks to enhance the safety and effectiveness of the treatment, addressing a significant unmet need in ovarian cancer care. Patients may benefit from more precise imaging and targeted therapy options.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with ovarian cancer, particularly those with advanced stages of the disease.
Not a fit: Patients with early-stage ovarian cancer or those without folate receptor expression may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic and therapeutic options for women with ovarian cancer.
How similar studies have performed: Previous research has shown promise in using targeted radiopharmaceuticals for cancer treatment, indicating potential success for this novel approach.
Where this research is happening
Raleigh, United States
- Oncurie INC. — Raleigh, United States (Active)
Researchers
- Principal investigator: Lapi, Suzanne Elizabeth — Oncurie INC.
- Study coordinator: Lapi, Suzanne Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.